The Japan facilities are located in Tokyo, Tokai and Osaka. The Tokyo site is the headquarters for the Pharmaceutical Custom Manufacturing Department. The Tokai facility produces high-purity oligonucleotide and peptides for large scale manufacturing (up to 12,000 L) using AJIPHASE® technology. The Osaka site is housed in Saito Life Science Park in two buildings – a manufacturing center and a research center. The teams at all sites are very dedicated and knowledgeable in the development and production of oligonucleotides and peptides.